Hypochlorous-Acid-Generating Electrochemical Scaffold for Treatment of Wound Biofilms.
Acinetobacter baumannii
/ drug effects
Animals
Anti-Bacterial Agents
/ metabolism
Bacterial Infections
/ microbiology
Biofilms
/ drug effects
Cell Survival
/ drug effects
Cells, Cultured
Ear, External
/ cytology
Electrochemical Techniques
/ instrumentation
Electrodes
Hypochlorous Acid
/ metabolism
Pseudomonas aeruginosa
/ drug effects
Staphylococcus aureus
/ drug effects
Swine
Time Factors
Wound Infection
/ microbiology
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
25 02 2019
25 02 2019
Historique:
received:
13
04
2018
accepted:
07
01
2019
entrez:
27
2
2019
pubmed:
26
2
2019
medline:
15
9
2020
Statut:
epublish
Résumé
Biofilm formation causes prolonged wound infections due to the dense biofilm structure, differential gene regulation to combat stress, and production of extracellular polymeric substances. Acinetobacter baumannii, Staphylococcus aureus, and Pseudomonas aeruginosa are three difficult-to-treat biofilm-forming bacteria frequently found in wound infections. This work describes a novel wound dressing in the form of an electrochemical scaffold (e-scaffold) that generates controlled, low concentrations of hypochlorous acid (HOCl) suitable for killing biofilm communities without substantially damaging host tissue. Production of HOCl near the e-scaffold surface was verified by measuring its concentration using needle-type microelectrodes. E-scaffolds producing 17, 10 and 7 mM HOCl completely eradicated S. aureus, A. baumannii, and P. aeruginosa biofilms after 3 hours, 2 hours, and 1 hour, respectively. Cytotoxicity and histopathological assessment showed no discernible harm to host tissues when e-scaffolds were applied to explant biofilms. The described strategy may provide a novel antibiotic-free strategy for treating persistent biofilm-associated infections, such as wound infections.
Identifiants
pubmed: 30804362
doi: 10.1038/s41598-019-38968-y
pii: 10.1038/s41598-019-38968-y
pmc: PMC6389966
doi:
Substances chimiques
Anti-Bacterial Agents
0
Hypochlorous Acid
712K4CDC10
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
2683Subventions
Organisme : NIAID NIH HHS
ID : R01 AI091594
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008336
Pays : United States
Références
N Engl J Med. 1999 Feb 18;340(7):493-501
pubmed: 10021469
Science. 1999 May 21;284(5418):1318-22
pubmed: 10334980
Appl Environ Microbiol. 1999 Oct;65(10):4594-600
pubmed: 10508094
Mol Microbiol. 1999 Dec;34(5):1082-93
pubmed: 10594832
Lancet. 2001 Jul 14;358(9276):135-8
pubmed: 11463434
J Appl Microbiol. 2001 Sep;91(3):525-32
pubmed: 11556920
J Invest Dermatol. 2003 Jul;121(1):1-12
pubmed: 12839557
Nat Prod Rep. 1992 Jun;9(3):199-215
pubmed: 1436736
J Microbiol Methods. 2003 Nov;55(2):475-9
pubmed: 14529971
Biofouling. 2004 Feb;20(1):1-23
pubmed: 15079889
Br J Nurs. 2005 Aug 11;14(15 Suppl):S30-2
pubmed: 16116416
East Afr Med J. 2005 Jul;82(7):331-6
pubmed: 16167704
Br J Nurs. 2006 Mar 23-Apr 12;15(6):S14-8
pubmed: 16628158
J Wound Care. 2006 Jan;15(1):33-7
pubmed: 16669304
Arch Dermatol Res. 2007 Feb;298(9):413-20
pubmed: 17091276
J Burns Wounds. 2007 Apr 11;6:e5
pubmed: 17492050
J Burns Wounds. 2007 Apr 11;6:e6
pubmed: 17492051
Wound Repair Regen. 2008 Jan-Feb;16(1):37-44
pubmed: 18086294
Curr Top Microbiol Immunol. 2008;322:207-28
pubmed: 18453278
Int Wound J. 2008 Jun;5(2):185-94
pubmed: 18494624
Histochem Cell Biol. 2008 Aug;130(2):281-97
pubmed: 18597105
J Bacteriol. 1948 Apr;55(4):451-8
pubmed: 18909070
Breast Cancer Res Treat. 2009 Oct;117(3):611-4
pubmed: 19219630
Int J Antimicrob Agents. 2010 Apr;35(4):322-32
pubmed: 20149602
J Antimicrob Chemother. 2010 Sep;65(9):1955-8
pubmed: 20615927
Plast Reconstr Surg. 2011 Jan;127 Suppl 1:93S-102S
pubmed: 21200278
Int Wound J. 2011 Jun;8(3):237-43
pubmed: 21470369
J Immunol. 2011 Jun 1;186(11):6585-96
pubmed: 21525381
J Burn Care Res. 2012 May-Jun;33(3):354-7
pubmed: 21979844
PLoS One. 2012;7(10):e47093
pubmed: 23077549
PLoS One. 2013;8(2):e55118
pubmed: 23390518
APMIS Suppl. 2013 May;(136):1-51
pubmed: 23635385
Curr Opin Microbiol. 2013 Oct;16(5):580-9
pubmed: 23880136
Diabet Foot Ankle. 2013 Sep 16;4:null
pubmed: 24049559
Int Wound J. 2015 Dec;12(6):693-8
pubmed: 24373098
Adv Skin Wound Care. 2014 Feb;27(2):65-9
pubmed: 24440863
Adv Wound Care (New Rochelle). 2012 Dec;1(6):238-243
pubmed: 24527312
Adv Wound Care (New Rochelle). 2013 Sep;2(7):389-399
pubmed: 24527355
Wound Repair Regen. 2014 Mar-Apr;22(2):174-86
pubmed: 24611980
Adv Wound Care (New Rochelle). 2014 Feb 1;3(2):81-90
pubmed: 24761348
Antimicrob Agents Chemother. 2014 Aug;58(8):4755-61
pubmed: 24913166
Biochemistry. 1989 Nov 14;28(23):9172-8
pubmed: 2557918
Wounds. 2014 Dec;26(12):342-50
pubmed: 25785777
Infect Immun. 2015 Jun;83(6):2531-41
pubmed: 25847960
Infect Immun. 2015 Aug;83(8):3026-34
pubmed: 25987705
Sci Rep. 2015 Oct 14;5:14908
pubmed: 26464174
Biofouling. 2015;31(9-10):745-58
pubmed: 26592420
Adv Mater. 2016 Jul;28(27):5470-84
pubmed: 27122372
Healthcare (Basel). 2014 Oct 27;2(4):445-67
pubmed: 27429287
Sci Rep. 2016 Oct 26;6:36003
pubmed: 27782161
Acta Biomater. 2017 Jan 15;48:451-460
pubmed: 27890730
Acta Biomater. 2017 Mar 1;50:344-352
pubmed: 28049020
Infect Immun. 1987 Oct;55(10):2518-25
pubmed: 2820883
Biochem J. 1988 Sep 15;254(3):685-92
pubmed: 2848494
Ostomy Wound Manage. 2015 May;61(5):S2-S19
pubmed: 28692424
Arch Phys Med Rehabil. 1985 Jul;66(7):443-6
pubmed: 3893385
Ann N Y Acad Sci. 1974;238:543-51
pubmed: 4216282
Ann Surg. 1973 Dec;178(6):745-53
pubmed: 4759406
Am J Surg. 1968 May;115(5):683-7
pubmed: 5300518
South Med J. 1969 Jul;62(7):795-801
pubmed: 5306004
Science. 1983 Nov 11;222(4624):625-8
pubmed: 6635660
Chemotherapy. 1997 Sep-Oct;43(5):340-5
pubmed: 9309367
Antimicrob Agents Chemother. 1998 Jul;42(7):1641-5
pubmed: 9660997
J Hosp Infect. 1999 Jan;41(1):59-70
pubmed: 9949966